Search

everythinglearnresearchcommunity

for

Search:↓

The Rotterdam Study found risk factors for elderly diseases, links between lifestyle and genetics with health conditions, and aimed to explore new areas like DNA methylation and sensory input effects on brain function.

The Rotterdam Study aims to understand disease causes in the elderly and has found new risk factors and genetic influences on various conditions.

Tissue engineering could be a future solution for hair loss, but it's currently expensive, complex, and hard to apply in real-world treatments.

Men with severe hair loss are more likely to have metabolic syndrome, a condition linked to heart disease.

The Facial Psoriasis Log-based Area and Severity Index is a more effective way to measure improvements in facial psoriasis than the traditional method.

Autoimmune and inflammatory processes are involved in both scarring and non-scarring types of hair loss.

Auto-portraits help evaluate scalp hair.

Lower growth factors linked to balding in androgenetic alopecia.

Walter P. Unger suggests using advanced hair transplant techniques for broader coverage, as they provide natural results and use donor tissue efficiently, while also recommending personalized planning due to the unpredictable progression of baldness.

Higher androgen levels do not cause baldness in men.

The new Cosmetic Surgery Scar Assessment Scale (CSSAS) was found to be simple and effective in evaluating scars from hair restoration surgeries.

Male pattern baldness is not a risk factor for heart disease based on cholesterol levels alone.

Hair loss in women is complex to diagnose and treat, and hair restoration should be done by experts. Using minoxidil before surgery can help manage post-surgery hair shock loss. The Follicular Unit Transplantation method is recommended for women due to its speed, no need for shaving, and better graft quality. Strategies like L, T, and reverse L patterns can help restore central hair density, and regenerative methods can improve graft survival in hair transplants.

Hair loss (androgenetic alopecia) mildly to moderately affects men's quality of life but not significantly their mental health.

No link found between hair loss severity and PSA levels in men.

Hair loss link to severe COVID-19 unclear.

Hair loss in men can be slowed or reversed with treatments like minoxidil and finasteride, but it resumes if treatment stops. It may also indicate early heart disease and obesity.

Minoxidil foam helps hair growth by increasing good proteins and decreasing bad pathways in men with hair loss.

Most COVID-19 patients in hospitals have androgenetic alopecia, more in men, suggesting a link between androgen sensitivity and severe COVID-19 symptoms.

Early balding, especially frontal, increases prostate cancer risk; more research needed.

A cancer drug caused unusual hair growth on a 100-year-old man's scalp and eyelashes.

Men's hair loss is not linked to their sex hormone levels, except for lower DHEAS in those with hair loss.

Androgenetic alopecia is linked to a higher risk of metabolic syndrome.

A trial showed that a new treatment is safe and effective for male pattern baldness, with most participants growing new hair.

Botulinum toxin-A may increase hair growth and reduce hair loss in men with baldness, and injecting near blood vessels can improve pain relief and last longer.

Botulinum toxin-A injections in the scalp can reduce hair loss and promote new hair growth in men with certain types of baldness.

Botulinum toxin injections can reduce hair loss and stimulate new hair growth in some men with male pattern baldness.

A man developed hair loss from testosterone treatment but improved with additional medication.

Altered hormones and insulin resistance are common in young men with early hair loss and linked to more severe cases.

Latanoprost 0.1% may effectively treat hair loss.